Old Web
English
Sign In
Acemap
>
Paper
>
Assessing the Risk of Apremilast Use for Psoriasis During the COVID-19 Pandemic.
Assessing the Risk of Apremilast Use for Psoriasis During the COVID-19 Pandemic.
2021
Donovan G. Kearns
Shelley K. Uppal
Vipawee S. Chat
Jashin J. Wu
Keywords:
Psoriasis
Clinical trial
Pandemic
Intensive care medicine
Apremilast
2019 20 coronavirus outbreak
Epidemiology
Coronavirus disease 2019
Medicine
MEDLINE
Correction
Source
Cite
Save
Machine Reading By IdeaReader
3
References
0
Citations
NaN
KQI
[]